Overview

An Efficacy and Safety Study to Compare Morphine 6-glucuronide (M6G) and Morphine in Patients Suffering With Post-Operative Pain for at Least 24 Hours

Status:
Completed

Trial end date:
2006-12-01

Target enrollment:

Participant gender:

Summary

To compare the incidence and severity of nausea in the study treatment groups, during the 18-hour period starting 6 hours after titration to pain relief; following confirmation of the assumption of non-inferiority between the two groups of pain relief over the 24 hour post-operative period. Pain relief and nausea will be determined by measuring the areas under the curves of pain intensity and nausea verbal rating scale scores.

Phase:

Phase 3

Details

Lead Sponsor:

Paion UK Ltd.

Collaborators:

Chiltern International Ltd.
HFL Ltd.

Treatments:

Morphine